United Therapeutics Quick Ratio 2006-2020 | UTHR

Historical quick ratio values for United Therapeutics (UTHR) over the last 10 years.
United Therapeutics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-06-30 $1.81B $0.26B 7.08
2020-03-31 $1.75B $0.21B 8.46
2019-12-31 $1.77B $0.46B 3.83
2019-09-30 $1.84B $0.47B 3.91
2019-06-30 $2.04B $0.46B 4.41
2019-03-31 $1.85B $0.27B 6.84
2018-12-31 $1.67B $0.28B 6.03
2018-09-30 $1.51B $0.37B 4.05
2018-06-30 $1.52B $0.35B 4.35
2018-03-31 $1.53B $0.32B 4.81
2017-12-31 $1.34B $0.45B 3.01
2017-09-30 $1.53B $0.79B 1.93
2017-06-30 $1.45B $0.84B 1.73
2017-03-31 $1.40B $0.43B 3.27
2016-12-31 $1.33B $0.33B 3.98
2016-09-30 $1.29B $0.32B 4.11
2016-06-30 $1.23B $0.29B 4.19
2016-03-31 $1.21B $0.36B 3.39
2015-12-31 $1.19B $0.44B 2.71
2015-09-30 $1.15B $0.56B 2.06
2015-06-30 $0.75B $0.54B 1.39
2015-03-31 $0.92B $0.65B 1.43
2014-12-31 $0.89B $0.50B 1.77
2014-09-30 $1.02B $0.76B 1.33
2014-06-30 $0.82B $0.66B 1.25
2014-03-31 $0.94B $0.66B 1.43
2013-12-31 $0.87B $0.69B 1.26
2013-09-30 $0.88B $0.47B 1.88
2013-06-30 $0.86B $0.41B 2.08
2013-03-31 $0.81B $0.18B 4.56
2012-12-31 $0.63B $0.18B 3.57
2012-09-30 $0.67B $0.23B 2.95
2012-06-30 $0.52B $0.19B 2.79
2012-03-31 $0.53B $0.18B 3.01
2011-12-31 $0.52B $0.21B 2.43
2011-09-30 $0.80B $0.43B 1.88
2011-06-30 $0.84B $0.45B 1.84
2011-03-31 $0.77B $0.44B 1.75
2010-12-31 $0.73B $0.43B 1.70
2010-09-30 $0.57B $0.40B 1.42
2010-06-30 $0.49B $0.37B 1.33
2010-03-31 $0.37B $0.33B 1.13
2009-12-31 $0.30B $0.33B 0.90
2009-09-30 $0.30B $0.30B 0.99
2009-06-30 $0.27B $0.08B 3.56
2009-03-31 $0.25B $0.06B 4.22
2008-12-31 $0.28B $0.06B 4.91
2008-09-30 $0.28B $0.29B 0.96
2008-06-30 $0.27B $0.29B 0.91
2008-03-31 $0.32B $0.06B 5.20
2007-12-31 $0.34B $0.27B 1.24
2007-09-30 $0.28B $0.03B 8.38
2007-06-30 $0.23B $0.02B 10.04
2007-03-31 $0.21B $0.02B 10.75
2006-12-31 $0.27B $0.02B 13.78
2006-09-30 $0.17B $0.02B 8.42
2006-06-30 $0.20B $0.02B 8.23
2006-03-31 $0.18B $0.02B 9.95
2005-12-31 $0.16B $0.02B 10.71
2005-09-30 $0.14B $0.02B 7.98
2005-06-30 $0.12B $0.02B 7.42
2005-03-31 $0.11B $0.01B 9.24
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.543B $1.449B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.741B 43.65
Takeda Pharmaceutical (TAK) Japan $58.610B 10.21
Astellas Pharma (ALPMY) Japan $28.578B 14.48
Eisai (ESALY) Japan $26.827B 22.67
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.966B 24.87
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.011B 45.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $10.808B 13.21
Neurocrine Biosciences (NBIX) United States $9.319B 36.08
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.720B 12.77
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $7.092B 44.93
Orion OYJ (ORINY) Finland $7.077B 24.56
Arrowhead Pharmaceuticals (ARWR) United States $4.480B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
FibroGen (FGEN) United States $3.961B 0.00
ChemoCentryx (CCXI) United States $3.640B 0.00
Nektar Therapeutics (NKTR) United States $3.560B 0.00
Hypermarcas (HYPMY) Brazil $3.553B 13.07
Sage Therapeutics (SAGE) United States $3.215B 0.00
PTC Therapeutics (PTCT) United States $3.122B 0.00
Pacira BioSciences (PCRX) United States $2.586B 67.98
Xencor (XNCR) United States $2.224B 0.00
Revolution Medicines (RVMD) United States $2.191B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.141B 10.36
Corcept Therapeutics (CORT) United States $2.059B 18.96
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.871B 0.00
Cronos Group (CRON) Canada $1.858B 0.00
USANA Health Sciences (USNA) United States $1.604B 15.11
Ironwood Pharmaceuticals (IRWD) United States $1.549B 10.76
Heron Therapeutics (HRTX) United States $1.410B 0.00
Indivior (INVVY) United States $1.348B 16.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.304B 12.43
Trillium Therapeutics (TRIL) Canada $1.271B 0.00
Zogenix (ZGNX) United States $1.252B 0.00
Karyopharm Therapeutics (KPTI) United States $1.194B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.082B 0.00
Esperion Therapeutics (ESPR) United States $1.041B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.984B 0.00
VAXART, INC (VXRT) United States $0.956B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.894B 556.75
Endo (ENDP) Ireland $0.722B 1.07
Tilray (TLRY) Canada $0.682B 0.00
ImmunoGen (IMGN) United States $0.674B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.672B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.666B 0.00
Collegium Pharmaceutical (COLL) United States $0.625B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.587B 0.00
Siga Technologies (SIGA) United States $0.567B 60.50
Aerie Pharmaceuticals (AERI) United States $0.563B 0.00
Radius Health (RDUS) United States $0.547B 0.00
Ocular Therapeutix (OCUL) United States $0.547B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Molecular Templates (MTEM) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.505B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.476B 0.00
Altimmune (ALT) United States $0.472B 0.00
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Organogenesis Holdings (ORGO) United States $0.401B 0.00
Akebia Therapeutics (AKBA) United States $0.400B 0.00
TherapeuticsMD (TXMD) United States $0.398B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.394B 19.67
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Redhill Biopharma (RDHL) Israel $0.369B 0.00
MEI Pharma (MEIP) United States $0.367B 0.00
DURECT (DRRX) United States $0.353B 0.00
PROFOUND MEDICL (PROF) Canada $0.343B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.338B 8.38
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.321B 0.00
Xeris Pharmaceuticals (XERS) United States $0.304B 0.00
Jounce Therapeutics (JNCE) United States $0.297B 14.08
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
Aquestive Therapeutics (AQST) United States $0.285B 0.00
Menlo Therapeutics (VYNE) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
Calithera Biosciences (CALA) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.245B 5.68
KalVista Pharmaceuticals (KALV) United States $0.241B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.222B 21.92
Avadel Pharmaceuticals (AVDL) Ireland $0.219B 0.00
Heat Biologics (HTBX) United States $0.209B 0.00
Taiwan Liposome (TLC) Taiwan $0.193B 0.00
CASI Pharmaceuticals (CASI) United States $0.191B 0.00
Nivalis Therapeutics (ALPN) United States $0.188B 0.00
OptiNose (OPTN) United States $0.188B 0.00
Otonomy (OTIC) United States $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Aclaris Therapeutics (ACRS) United States $0.107B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.105B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Biomerica (BMRA) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Novan (NOVN) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.054B 0.00
CV Sciences (CVSI) United States $0.054B 0.00
SCYNEXIS (SCYX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
India Globalization Capital (IGC) United States $0.049B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.047B 0.00
GTx (ONCT) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
IsoRay (ISR) United States $0.040B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
AgeX Therapeutics (AGE) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Sundial Growers (SNDL) Canada $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 24.09
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00